AffiliationInnovative & Intensified Disease Management, Neglected Tropical Diseases, WHO, Geneva, Switzerland. firstname.lastname@example.org
MetadataShow full item record
AbstractChagas disease (American trypanosomiasis) is endemic in 21 countries of the Americas, where control is largely focused on elimination of the domestic insect vectors (Triatominae) coupled with measures to extend and improve the screening of blood donors in order to avoid tranfusional transmission. Through national programmes and multinational initiatives coordinated by WHO-PAHO, much has been accomplished in these domains in terms of reducing transmission. Attention now turns to consolidating the successes in interrupting transmission, and improved treatment for those already infected and those who may become affected in the future. This article, based on technical discussions at the "Epidemiological and Sociological Determinants of Chagas Disease, Basic Information to Establish a Surveillance and Control Policy " meeting in Rio de Janeiro, is designed to open the debate on appropriate strategies for continuation of the successful initiatives against Chagas disease.
- The impact of Chagas disease control in Latin America: a review.
- Authors: Dias JC, Silveira AC, Schofield CJ
- Issue date: 2002 Jul
- Recognizing and meeting the challenge of Chagas disease in the USA.
- Authors: Bowling J, Walter EA
- Issue date: 2009 Dec
- Etiological treatment for infection by Trypanosoma cruzi.
- Authors: Amato Neto V
- Issue date: 1999
- [Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation].
- Authors: Coura JR, de Abreu LL, Willcox HP, Petana W
- Issue date: 1997 Mar-Apr
- [Treatment of Chagas' disease].
- Authors: Apt W
- Issue date: 1985 Feb